Popular on EntSun
- Sea Tales Strengthens U.S. Leadership Team as Retail Expansion Accelerates - 447
- Stitt Entertainment Names Tristan Xavier Lead Stylist - 377
- ChargeOn Announces Conversational Payment Management Solution - 375
- Mecca to Mars: Earth's Escape? - 283
- Robert DeMaio, Phinge CEO to Speak at 30th IIPLA 2026 on Securing IP, User Data & Digital Sovereignty via Verified App-less Tech. Attend the Live Q&A! - 266
- Rehearsals Begin on 'The Call List' by Brian James Polak - 254
- Free JavaScript Charting Library ProEssentialsJS Permits Commercial Use. Highcharts, SciChart and LightningChart Free Tiers Do Not - 252
- Volant Announces Major Partnership with the STEM Racing Canada Program to CHAMPION YOUTH ENGINEERING - 241
- Big Panic Records Announces "African Sunshine" by Believe, Shirley Jones & Omasta - 231
- Yalil Guerra's "Clave" to Receive World Premiere in New Symphonic Version at The Soraya - 214
Similar on EntSun
- Nutriband Inc. (N A S D A Q: NTRB) Breaks Into Uncharted Territory: 52-Week High Eclipsed as Shares Surge 22% —AVERSA™ Puts Investors on High Alert
- Transformational $104 Million Musculoskeletal Healthcare Opportunity as Expansion Strategy Accelerates for Cardiff Lexington Corp (Stock Symbol: CDIX)
- Woodside Rehab & Nursing Enters a New Era of Clinical Excellence and Growth
- JoCa's Echoes of Haworth Sells Out on Opening Night in Mexico City; Artist Heads to San Luis Potosí and Miami Art Week
- Acuvance Coker Study Finds Experience, Not Supply, Is the Biggest Advanced Practice Provider Workforce Challenge
- Independent Autopsies Are Changing Civil Cases: Kansas City Forensic Explains Why Families Are Seeking Second Opinions
- Regional Magazines Shine at IRMA Awards
- Warrant Activity, AVERSA™ Progress and a Potentially Transformative Fall Take Center Stage: Nutriband Inc. (N A S D A Q: NTRB)
- Michael H. Kaplan Advocates for Seriously Injured Colorado Workers Who Need In-Home Care
- Infinity Infusion Solutions Named Finalist for D Magazine's D CEO 2026 Excellence in Healthcare Awards
Limping dogs in LA can now jump for joy with a revolutionary joint treatment
EntSun News/10950673
Simon Veterinary Surgical offers new Synovetin OA® to treat lameness in dogs
LOS ANGELES - EntSun -- Los Angeles dogs suffering from pain, lameness, and reduced activity due to arthritis can now find convenient, long-lasting relief at Simon Veterinary Surgical thanks to a new treatment offered by Dr. Patricia Simon.
Synovetin OA® is a treatment placed right in the dog's joints that reduces the inflammation and pain of osteoarthritis for up to one full year.
"For dogs with chronic joint pain, Synovetin OA is a simple, long-lasting, and safe treatment," according to Dr. Simon. "It treats inflammation and pain right where it happens – it doesn't go throughout the dog like pills, where you could have side effects."
Nearly 25% of US dogs suffer from osteoarthritis, causing pain, lameness, limping, limited movement and a poor quality of life. Many current treatments require daily administrations to provide short-term relief. However, clinical trial data has shown that just one treatment with Synovetin OA relieves pain and inflammation and improves mobility for up to one year.
More on EntSun News
"We're excited to be one of the very first veterinary hospitals offering Synovetin OA," Dr. Simon said. "Though my specialty is orthopedic surgery, it is no longer the only option for my patients."
This procedure involves the use of radiotherapy and Dr. Simon's team has completed the necessary training and licensing required to use Synovetin OA in all joints - other licensed clinics are usually only approved for elbows.
The active agent of Synovetin OA, developed by Exubrion Therapeutics®, is tin-117m, a unique medical radiotherapeutic. Synovetin OA:
More on EntSun News
Simon Veterinary Surgical is a woman-owned small business serving the Greater Los Angeles area. Dr. Patricia Simon is a rare veterinary surgeon with comprehensive knowledge, experience, and proficiency in a wide range of orthopedic and advanced soft tissue procedures. Alongside her expert team, Dr. Simon has become one of the most sought after surgeons in the area. Their pet hospital facilities are fully equipped, allowing them to offer exceptional veterinary care, surgery, diagnostic imaging, and lab work in one location.
For more information about the procedure, contact Simon Veterinary Surgical at (310) 402-3573 or info@simonvetsurgical.com, or visit us at simonvetsurgical.com.
Information about Synovetin OA can be found at activedognow.com.
Synovetin OA® is a treatment placed right in the dog's joints that reduces the inflammation and pain of osteoarthritis for up to one full year.
"For dogs with chronic joint pain, Synovetin OA is a simple, long-lasting, and safe treatment," according to Dr. Simon. "It treats inflammation and pain right where it happens – it doesn't go throughout the dog like pills, where you could have side effects."
Nearly 25% of US dogs suffer from osteoarthritis, causing pain, lameness, limping, limited movement and a poor quality of life. Many current treatments require daily administrations to provide short-term relief. However, clinical trial data has shown that just one treatment with Synovetin OA relieves pain and inflammation and improves mobility for up to one year.
More on EntSun News
- Halloween Fun with Circus Harmony All October at City Museum
- New Metallized PE Film from Pregis Brings Recyclability to High-Barrier Food Packaging at Pack Expo International in Chicago
- Drake Brings Jimmy Brooks Back as KayeDinero Turns Banks Ave Into a Nighttime Visual
- Transformational $104 Million Musculoskeletal Healthcare Opportunity as Expansion Strategy Accelerates for Cardiff Lexington Corp (Stock Symbol: CDIX)
- PropAccount.com Launches Marketing Hub Within PropGenie, Giving Prop Firm Operators an Automated Marketing Team
"We're excited to be one of the very first veterinary hospitals offering Synovetin OA," Dr. Simon said. "Though my specialty is orthopedic surgery, it is no longer the only option for my patients."
This procedure involves the use of radiotherapy and Dr. Simon's team has completed the necessary training and licensing required to use Synovetin OA in all joints - other licensed clinics are usually only approved for elbows.
The active agent of Synovetin OA, developed by Exubrion Therapeutics®, is tin-117m, a unique medical radiotherapeutic. Synovetin OA:
- Reduces inflammation and relieves chronic canine OA pain
- Eliminates the key drivers of inflammation and pain
- Is administered just once a year and can be re-administered again after a year, if needed
- Is safe; no significant side effects were seen during clinical trials
- Is given in the hospital and the dog can normally return home the same day
- Can be used along with other treatments for OA pain management, if needed
More on EntSun News
- Save 15 Percent Off Florida Keys Accommodations with KeysCaribbean's Advance Purchase Rate Discount
- Woodside Rehab & Nursing Enters a New Era of Clinical Excellence and Growth
- Thar Process Partners with French Leader ExtrateX to Bring Prep to Process-Scale SFC to Europe
- iPOP! Alum Lucas Till Stars Alongside Zach Braff in Upcoming Film Clean Hands
- Hispaniola Cigars Distributor Explores the Vodou Spirit Behind Its Baron Samedi Cigar in Educatio
Simon Veterinary Surgical is a woman-owned small business serving the Greater Los Angeles area. Dr. Patricia Simon is a rare veterinary surgeon with comprehensive knowledge, experience, and proficiency in a wide range of orthopedic and advanced soft tissue procedures. Alongside her expert team, Dr. Simon has become one of the most sought after surgeons in the area. Their pet hospital facilities are fully equipped, allowing them to offer exceptional veterinary care, surgery, diagnostic imaging, and lab work in one location.
For more information about the procedure, contact Simon Veterinary Surgical at (310) 402-3573 or info@simonvetsurgical.com, or visit us at simonvetsurgical.com.
Information about Synovetin OA can be found at activedognow.com.
Source: Simon Veterinary Surgical
Filed Under: Lifestyle
0 Comments
Latest on EntSun News
- Radio Drive's New Album Walk With Me Delivers Two GRAMMY® Submissions Across Rock and Alternative Categories
- Kaplan Morrell and Attorney Jacqui Condon Selected to Represent Professional Women's Soccer Players in Workers' Compensation Matters
- ClearSight Therapeutics Receives NIH SBIR Phase I Award for Conjunctivitis and EKC Research
- Follow No One Entertainment Launches AI-Free Record Label & Global Broadcast Network
- Sidow Sobrino on Michael Jackson and the Art of Building an Identity of Your Own
- Lunai Bioworks (N A S D A Q: LNAI) Takes Parkinson's Discovery to the Next Level With Exclusive Tanaist Agreement
- Murder is on the Menu for Halloween Weekend at Georgia's Lanier Islands Resort
- The DMV Jazz Series returns to New Spire Arts with Five New Artists
- Revenue Optics Names Prat Patibandla Director of Growth Marketing
- Independent Autopsies Are Changing Civil Cases: Kansas City Forensic Explains Why Families Are Seeking Second Opinions
- JEGS Launches Transformed Digital Commerce Platform Powered by PhaseZero
- Subject matter experts: Present your ideas at IISE Annual Conference 2027 in Louisville
- Cummings Graduate Institute Celebrates New Doctor of Behavioral Health Graduates
- Visit London Appoints The SEO Works for AI-First Search Strategy
- King of the Wild Frontier Reading at North Coast Repertory Theatre
- For One-Hit Wonder Day: Treat yourself to Two Great Songs called "Big Bucks" and "Run For Office"
- Dual-Media Launches The Studio Lab™
- Inglewood Associates and Gordon Brothers Provide Update on Sale Process for 925 Euclid Avenue in Cleveland
- Century Fasteners Corp. Exhibiting at the 2026 International Fastener Expo
- Las Vegas Attorney Thomas Boley Publishes Free Plain-English Guide to 100 Nevada Criminal Laws, in English and Spanish
